Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.
2.

Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.

Scrivener S, Goddard RV, Kaminski ER, Prentice AG.

Leuk Lymphoma. 2003 Mar;44(3):383-9. Review.

PMID:
12688308
3.

Definition of a target for immunotherapy and results of the first Peptide vaccination study in chronic lymphocytic leukemia.

Tabarkiewicz J, Giannopoulos K.

Transplant Proc. 2010 Oct;42(8):3293-6. doi: 10.1016/j.transproceed.2010.07.022. Review.

PMID:
20970674
4.

T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil.

Mellstedt H, Choudhury A.

Cancer Immunol Immunother. 2006 Feb;55(2):210-20. Epub 2005 May 19. Review.

PMID:
15906026
5.

Vaccine- and immune-based therapy in chronic lymphocytic leukemia.

Le Dieu R, Gribben J.

Semin Oncol. 2006 Apr;33(2):220-9. Review.

PMID:
16616069
6.

CD40 activation: potential for specific immunotherapy in B-CLL.

von Bergwelt-Baildon M, Maecker B, Schultze J, Gribben JG.

Ann Oncol. 2004 Jun;15(6):853-7. Review.

7.

Autoimmune complications of chronic lymphocytic leukemia.

Hamblin TJ.

Semin Oncol. 2006 Apr;33(2):230-9. Review.

PMID:
16616070
8.

Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia.

Ferrarini M, Chiorazzi N.

Semin Hematol. 2004 Jul;41(3):207-23. Review.

PMID:
15269881
9.

CD154 gene therapy for human B-cell malignancies.

Messmer D, Kipps TJ.

Ann N Y Acad Sci. 2005 Dec;1062:51-60. Review.

PMID:
16461788
10.

Differential effects on CLL cell survival exerted by different microenvironmental elements.

Ghia P, Circosta P, Scielzo C, Vallario A, Camporeale A, Granziero L, Caligaris-Cappio F.

Curr Top Microbiol Immunol. 2005;294:135-45. Review.

PMID:
16323430
Items per page

Supplemental Content

Write to the Help Desk